Access Pharmaceuticals
About Us
Board of Directors
Senior Management
Product Programs
MuGard
Fact Sheet
MuGard.com
Order Form
Cobalamin mediated oral drug delivery
CobaCyte - Cobalamin targeted delivery
Publications
Business Development
Investor Relations
SEC Filings
Newsroom
2013
2012
2011
Contact Us
About Us
Board of Directors
Senior Management
Contact
2600 Stemmons Freeway,
Suite 176
Dallas, TX 75207-2107
Tel: (214) 905-5100
Fax: (214) 905-5101
info@accesspharma.com
Sign up for news alerts!
Senior Management
Jeffrey B. Davis, President and Chief Executive Officer
President, SCO Financial Group LLC.
Senior Vice President and Chief Financial Officer of a healthcare technology company.
Vice President, Corporate Finance, at Deutsche Morgan Grenfell.
Senior marketing and product management positions at AT&T Bell Laboratories.
Marketing and Product Manager at Philips Medical Systems North America.
MBA, The Wharton School, University of Pennsylvania.
BS Biomedical Engineering, Boston University.
David P. Nowotnik, Ph.D., Senior Vice President Research and Development
Senior Director, Product Development, Guilford Pharmaceuticals, Inc.
Group Leader, Bristol-Myers Squibb.
Section Leader, Amersham International.
Research Chemist, Tate and Lyle and Aspro-Nicholas.
PhD, Organic Chemistry, University of London.
Stephen B. Thompson, Vice President and CFO
Controller and Administration Manager, API.
Controller, Robert E. Woolley, Inc., a hotel real estate company.
Controller, OKC Limited Partnership, an oil and gas company.
Accounting and finance, Santa Fe International Corporation.
Frank Jacobucci, Vice President of Sales and Marketing
Over 20 years experience in sales management.
Senior sales executive positions at oncology-focused companies including MGI Pharma, Genetics Institute, Wyeth Oncology, Aventis, Precision Therapeutics and CRC Oncology Services.
Anthony Mottola, Vice President, Managed Care & Market Access
Vice President, BioScrip
Associate Director National Accounts, Novartis
Sales Management Oncology Division, Pfizer, US Bioservices, Abbott Laboratories
Snapshot Quote
ACCP (OTCBB)
Last Trade
0.00
Change
N/A
Open
N/A
Bid
N/A
Ask
N/A
Volume
N/A
quotes delayed at least 15 minutes
Product Programs
Select Product
MuGard
Cobalamin mediated oral drug delivery
CobaCyte - Cobalamin targeted delivery
Publications
Latest News & Events
04.29.13
Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress
03.20.13
ACCESS PHARMACEUTICALS TO HOST FOURTH QUARTER AND FISCAL YEAR INVESTOR CALL ON WEDNESDAY, APRIL 3RD AT 11:00AM ET
11.18.12
Access pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
10.25.12
ACCESS PHARMACEUTICALS ANNOUNCES PRIVATE PLACEMENT FINANCING
08.23.12
Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012